Core Viewpoint - Artificial intelligence (AI) is viewed as a long-term investment opportunity, with concerns about a potential bubble in AI-focused stocks [1] Group 1: Eli Lilly - Eli Lilly is experiencing significant growth, particularly in the weight-loss drug market, leading to rapidly increasing revenue and earnings [6] - The company's dividend program has seen a 239.2% increase over the past decade, although its forward yield is 0.6%, lower than the S&P 500 average of 1.2% [7] - Eli Lilly is leveraging AI to enhance drug development processes, having built a powerful computer in collaboration with Nvidia, which could lead to faster drug launches and improved profit margins [7][8] - The company's success is not solely dependent on AI advancements, as it is already performing well independently of broader AI industry trends [8] Group 2: Medtronic - Medtronic is a leading medical device manufacturer with a diverse product portfolio that ensures consistent revenue and earnings [9] - The company is gradually integrating AI into its operations, improving product performance, such as in the LINQ II cardiac monitor, which has benefited from AI algorithms to reduce false alerts [9]